Bluebird bio secures gene approval

By Megan Brodie 4 years ago | In Cell and gene therapies
  • 4 years ago

19 August 2022 Bluebird bio has received FDA approval for its one-time beta-thalassemia gene therapy…

This is subscriber-only content. Please login to continue reading.

Recent News

Top Reads